EMEA-002247-PIP03-17-M01
- Active Substance
Ivosidenib
- Therapeutic area
Oncology
- Decision number
P/0001/2024
- PIP number
EMEA-002247-PIP03-17-M01
- Pharmaceutical form(s)
Film-coated tablet
- Condition(s) / indication(s)
Treatment of acute myeloid leukaemia
- Route(s) of administration
Oral use
- Contact for public enquiries
- Decision type
PM: decision on the application for modification of an agreed PIP
- Decision date
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
